Geron Corp (NASDAQ:GERN)
| 3.67 Delayed Data As of 3:59pm ET |  +0.11 / +3.09%Today’s Change | 1.18 Today|||52-Week Range 3.84 | +51.65% Year-to-Date |
Latest GERN News | Press Releases
| Geron (GERN) Just Flashed Golden Cross Signal: Do You Buy? Jun 01 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 3.56 |
| Today’s open | 3.57 |
| Day’s range | 3.56 - 3.70 |
| Volume | 202,295 |
| Average volume (3 months) | 5,640,373 |
| Market cap | $1.9B |
Data as of 3:59pm ET, 06/08/2023
Growth & Valuation
| Earnings growth (last year) | -5.14% |
| Earnings growth (this year) | -0.90% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | -57.21% |
| P/E ratio | NM |
| Price/Sales | 1,546.14 |
| Price/Book | 17.78 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IOVAIovance Biotherapeut... | -0.25 | -3.03% |
| ---- | ||
| RCKTRocket Pharmaceutica... | +0.26 | +1.12% |
| ---- |
Data as of 4:00pm ET, 06/08/2023
Financials
| Next reporting date | August 2, 2023 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $596.0K |
| Annual profit (last year) | -$141.9M |
| Net profit margin | -23,808.89% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Foster City, California |
Forecasts
